NEGXF (NexgenRx) Cyclically Adjusted Book per Share: $0.06 (As of Mar. 2026)


NEGXF NexgenRx Inc NEGXF
40 GF Score
Price $0.33
GF Value $0.22
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is NexgenRx Cyclically Adjusted Book per Share?

NexgenRx NEGXF 40 Cyclically Adjusted Book per Share is $0.06 as of Mar. 2026. GuruFocus rates NEGXF with a GF Score™ of 40/100 and a GF Value™ of $0.22 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

NexgenRx's adjusted book value per share for the three months ended in Mar. 2026 was $0.073. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.06 for the trailing ten years ended in Mar. 2026.

During the past 12 months, NexgenRx's average Cyclically Adjusted Book Growth Rate was 16.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 26.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 40.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of NexgenRx was 58.70% per year. The lowest was 15.70% per year. And the median was 35.70% per year.

As of today (2026-07-05), NexgenRx's current stock price is $0.325. NexgenRx's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.06. NexgenRx's Cyclically Adjusted PB Ratio of today is 5.42.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of NexgenRx was 41.00. The lowest was 4.00. And the median was 6.75.


NexgenRx  (OTCPK:NEGXF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

NexgenRx's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.325/0.06
=5.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of NexgenRx was 41.00. The lowest was 4.00. And the median was 6.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


NexgenRx Cyclically Adjusted Book per Share Related Terms


NexgenRx Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for NexgenRx's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NexgenRx Cyclically Adjusted Book per Share Chart

NexgenRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.04 0.04 0.04

NexgenRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.03 0.04 0.06

NEGXF vs VEEV, BTSG, TEM: Cyclically Adjusted Book per Share Comparison

For the Health Information Services subindustry, NexgenRx's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NexgenRx Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NexgenRx's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NexgenRx's Cyclically Adjusted PB Ratio falls into.


NEGXF
40GF Score
NexgenRx Inc NEGXF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NexgenRx Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NexgenRx's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.073/132.2600*132.2600
=0.073

Current CPI (Mar. 2026) = 132.2600.

NexgenRx Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.001 102.002 0.001
201609 0.001 101.765 0.001
201612 0.009 101.449 0.012
201703 0.010 102.634 0.013
201706 0.009 103.029 0.012
201709 0.008 103.345 0.010
201712 0.023 103.345 0.029
201803 0.021 105.004 0.026
201806 0.017 105.557 0.021
201809 0.020 105.636 0.025
201812 0.021 105.399 0.026
201903 0.022 106.979 0.027
201906 0.022 107.690 0.027
201909 0.020 107.611 0.025
201912 0.020 107.769 0.025
202003 0.022 107.927 0.027
202006 0.028 108.401 0.034
202009 0.034 108.164 0.042
202012 0.044 108.559 0.054
202103 0.050 110.298 0.060
202106 0.055 111.720 0.065
202109 0.058 112.905 0.068
202112 0.090 113.774 0.105
202203 0.091 117.646 0.102
202206 0.089 120.806 0.097
202209 0.081 120.648 0.089
202212 0.075 120.964 0.082
202303 0.077 122.702 0.083
202306 0.074 124.203 0.079
202309 0.072 125.230 0.076
202312 0.064 125.072 0.068
202403 0.069 126.258 0.072
202406 0.065 127.522 0.067
202409 0.067 127.285 0.070
202412 0.059 127.364 0.061
202503 0.063 129.181 0.065
202506 0.066 129.892 0.067
202509 0.067 130.290 0.068
202512 0.061 130.370 0.062
202603 0.073 132.260 0.073

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.06 mean?
NexgenRx (NEGXF) has a Cyclically Adjusted Book per Share of $0.06 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NexgenRx and its competitors.
Is NexgenRx's Cyclically Adjusted Book per Share too high?
NexgenRx's current Cyclically Adjusted Book per Share is $0.06. Overall, NexgenRx has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NexgenRx's Cyclically Adjusted Book per Share compare to VEEV and BTSG?
NexgenRx's Cyclically Adjusted Book per Share of $0.06 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Book per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NexgenRx and its competitors. NexgenRx's current Cyclically Adjusted Book per Share is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexgenRx stock overvalued right now?
Based on GuruFocus' analysis, NexgenRx (NEGXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.22, compared to a current price of $0.33 — trading 47.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is $0.06. NexgenRx's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For NexgenRx (NEGXF), the current Cyclically Adjusted Book per Share is $0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NexgenRx (NEGXF) Overvalued in 2026?

Based on GuruFocus' analysis, NexgenRx stock appears to be overvalued. The current stock price of $0.33 is trading 47.7% above its estimated GF Value™ of $0.22. GuruFocus considers NexgenRx to be Modestly Overvalued.

Key valuation signals for NEGXF:

  • Cyclically Adjusted Book per Share: $0.06
  • GF Value™: $0.22 vs. price of $0.33 (47.7% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the NEGXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NexgenRx Business Description

Other Exchanges NXG:Canada
Address 191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.
40GF Score

Get the complete analysis for NEGXF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.33
Price
$0.22
GF Value